| Genomic correlates of response to everolimus in aggressive radioiodine-refractory thyroid cancer: a phase II study GJ Hanna, NL Busaidy, NG Chau, LJ Wirth, JA Barletta, A Calles, ... Clinical Cancer Research 24 (7), 1546-1553, 2018 | 107 | 2018 |
| The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana‐Farber/Brigham and Women’s Cancer Center multidisciplinary guideline A Sultan, GJ Hanna, DN Margalit, N Chau, LA Goguen, FM Marty, ... The Oncologist 22 (3), 343-350, 2017 | 93 | 2017 |
| Incorporation of next-generation sequencing into routine clinical care to direct treatment of head and neck squamous cell carcinoma NG Chau, YY Li, VY Jo, G Rabinowits, JH Lorch, RB Tishler, DN Margalit, ... Clinical cancer research 22 (12), 2939-2949, 2016 | 60 | 2016 |
| Comparative analysis of microRNA expression among benign and malignant tongue tissue and plasma of patients with tongue cancer G Rabinowits, M Bowden, LM Flores, S Verselis, V Vergara, VY Jo, ... Frontiers in oncology 7, 191, 2017 | 41 | 2017 |
| CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1–Dependent IGF-1 Signaling H Sun, DC Lin, Q Cao, X Guo, H Marijon, Z Zhao, S Gery, L Xu, H Yang, ... Cancer research 76 (9), 2687-2697, 2016 | 35 | 2016 |
| Metabolic regulation of glioma stem-like cells in the tumor micro-environment TM Thomas, SY John Cancer letters 408, 174-181, 2017 | 29 | 2017 |
| Genomic heterogeneity and exceptional response to dual pathway inhibition in anaplastic thyroid cancer WJ Gibson, DT Ruan, VA Paulson, JA Barletta, GJ Hanna, S Kraft, ... Clinical Cancer Research 23 (9), 2367-2373, 2017 | 28 | 2017 |
| IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation L Pan, ME Lemieux, T Thomas, JM Rogers, CH Lipper, W Lee, C Johnson, ... elife 9, e58081, 2020 | 14 | 2020 |
| ZEB1 is a transcription factor that is prognostic and predictive in diffuse gliomas LA Edwards, S Kim, M Madany, M Nuno, T Thomas, A Li, D Berel, BS Lee, ... Frontiers in neurology 9, 1199, 2019 | 13 | 2019 |
| The curious case of ZEB1 M Madany, T Thomas, LA Edwards Discoveries 6 (4), 2018 | 13 | 2018 |
| Immunobiology and immunotherapeutic targeting of glioma stem cells M Madany, TM Thomas, L Edwards, JS Yu Stem Cell Biology in Neoplasms of the Central Nervous System, 139-166, 2015 | 12 | 2015 |
| Microcystic adnexal carcinoma of the face treated with definitive chemoradiation: a case report and review of the literature DW Kim, G Lee, MB Lam, EJ Harris, AC Lam, T Thomas, NG Chau, ... Advances in Radiation Oncology 5 (2), 301-310, 2020 | 11 | 2020 |
| Elevated asparagine biosynthesis drives brain tumor stem cell metabolic plasticity and resistance to oxidative stress TM Thomas, K Miyaguchi, LA Edwards, H Wang, H Wollebo, L Aiguo, ... Molecular Cancer Research 19 (8), 1375-1388, 2021 | 7 | 2021 |
| Patient immunosuppression and the association with cancer-specific outcomes after treatment of squamous cell carcinoma of the oropharynx DN Margalit, JD Schoenfeld, B Rawal, M Puzanov, RI Haddad, ... International Journal of Radiation Oncology, Biology, Physics 94 (4), 913, 2016 | 2 | 2016 |
| ZEB1 loss increases glioma stem cell tumorigenicity and resistance to chemoradiation GK Hanna, M Madany, ASMS Tay, LA Edwards, S Kim, JS Michael, ... Journal of Neurosurgery 138 (5), 1313-1324, 2022 | 1 | 2022 |
| Elevated Asparagine Biosynthesis Drives Brain Tumor Stem Cell Metabolic Plasticity and Resistance to Oxidative Stress (vol 19, pg 1375, 2021) TM Thomas, K Miyaguchi, LA Edwards, H Wang, H Wollebo, L Aiguo MOLECULAR CANCER RESEARCH 19 (8), 1437-1437, 2021 | | 2021 |
| ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas. T Thomas, A Li, D Berel, BS Lee, M Liu, K Black, X Fan, W Zhang, J Yu, ... | | 2018 |
| CEDARS SINAI HEALTH SYSTEM TM Thomas CEDARS-SINAI MEDICAL CENTER LOS ANGELES, CALIFORNIA, 2017 | | 2017 |
| Abstract LB-227: Truncal activating MAPK and PI3K pathway alterations and exceptional response to dual pathway inhibition in anaplastic thyroid cancer WJ Gibson, DT Ruan, VA Paulson, JA Barletta, GJ Hanna, S Kraft, ... Cancer Research 76 (14_Supplement), LB-227-LB-227, 2016 | | 2016 |
| Truncal activating MAPK and PI3K pathway alterations and exceptional response to dual pathway inhibition in anaplastic thyroid cancer WJ Gibson, DT Ruan, VA Paulson, JA Barletta, GJ Hanna, S Kraft, ... CANCER RESEARCH 76, 2016 | | 2016 |
Haibo SunUniversity of California, San FranciscoVerified email at ucsf.edu
